The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Current and future perspectives on lung cancer screening in Latin America
Ricardo Sales dos Santos, MD, PhD, Hospital Israelita Albert Einstein, São Paulo, Brazil, discusses present challenges and opportunities for implementing lung cancer screening in Latin America. Whilst low-dose CT scans are important for screening, various issues persist in terms of fragmented healthcare systems. Public healthcare systems tend to lack the necessary infrastructure, and patients may not have readily accessible healthcare. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
